Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
25.22
+1.60 (6.77%)
Sep 21, 2026, 11:55 AM EDT - Market open

Amphastar Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
730.02720.53719.89723.31722.68730.66731.97723.55712.89676.21644.4601.31540.89518.64498.99484.85476.92455.12437.77412.8
Revenue Growth
1.02%-1.39%-1.65%-0.03%1.37%8.05%13.59%20.33%31.80%30.38%29.14%24.02%13.41%13.96%13.98%17.45%24.19%23.61%25.13%22.38%
Gross Profit
348.11341.13356.06357.04360.33369.01373.86383.35392.51367.38351.12328.85276.26269.57248.86233.93226.6210.62199.74180.34
Operating Income
137.39139.84163.5173.04181.67194.7205.42214.26232.59211.56196.99183.54131.39122.02107.595.7297.268371.6950.81
Net Income
78.5579.2398.09111.63134.71141.63159.52157.72166.52154.69137.55135.29101.9493.1791.3977.2390.9181.3362.1236.08
Earnings Per Share
1.691.672.032.272.682.773.063.013.152.912.602.561.941.771.741.491.771.621.250.72
EPS Growth
-37.04%-39.73%-33.66%-24.59%-14.81%-4.83%17.69%17.38%62.07%64.18%49.43%72.29%9.55%9.16%39.20%106.09%739.76%3024.16%4090.97%435.38%

Revenue by Geography

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
United States
683.21677.87681.42684.96691.2700.61707.68707.87699.42666.89635.19591.06530.79507.68486.83473.36463.41437.81419.87392.92
China
9.855.593.184.452.754.024.344.515.164.784.514.424.313.894.73.645.475.836.025.48
France
36.9637.0735.2833.8928.7326.0319.9511.178.314.544.75.835.797.077.467.868.0411.4711.8814.41
Total
730.02720.53719.89723.31722.68730.66731.97723.55712.89676.21644.4601.31540.89518.64498.99484.85476.92455.12437.77412.8

Cash & Debt

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
290.12291.95282.81276.21231.75236.88221.65250.49217.78289.56256.81299.88163.14192.89175.76184.09183.39187.01136.67114.63
Total Debt
688.32686.38656656.77655.5652.53650.55629.85620.58627.12623.64672.56528.74102.03102.58103.24103.92105.28104.66106.14
Net Cash (Debt)
-398.2-394.43-373.19-380.56-423.75-415.65-428.9-379.36-402.81-337.56-366.84-372.68-365.690.8773.1880.8579.4781.7432.018.5
Net Cash Growth
-------------11.17%128.62%851.70%56.28%61.98%-16.53%-73.89%
Net Cash Per Share
-8.59-8.33-7.74-7.73-8.42-8.11-8.24-7.23-7.60-6.34-6.92-7.07-6.981.731.401.551.551.620.640.17

Cash Flow & CapEx

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
184.61168.88156.12152.28159.66193.17213.39208.23212.6198.41183.5174.87130.9178.889.18114.496.59125.9397.9974.45
Capital Expenditures
-31.72-33.69-34.88-39.02-47.47-42.95-41.04-38.07-34.47-37.48-38.17-35.03-30.46-27.37-24.03-24.6-26.2-25.98-27.46-29.91
Free Cash Flow
152.89135.19121.23113.26112.19150.23172.35170.15178.13160.93145.34139.83100.4451.4365.1589.7970.3999.9670.5444.54
Free Cash Flow Growth
36.28%-10.01%-29.66%-33.44%-37.02%-6.65%18.58%21.68%77.34%212.94%123.09%55.72%42.69%-48.55%-7.64%101.61%34.43%121.40%201.30%240.28%

Margins

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
47.69%47.34%49.46%49.36%49.86%50.50%51.08%52.98%55.06%54.33%54.49%54.69%51.08%51.98%49.87%48.25%47.51%46.28%45.63%43.69%
Operating Margin
18.82%19.41%22.71%23.92%25.14%26.65%28.06%29.61%32.63%31.29%30.57%30.52%24.29%23.53%21.54%19.74%20.39%18.24%16.38%12.31%
Pretax Margin
13.98%14.27%17.17%18.76%22.39%23.64%25.85%25.72%28.28%27.20%26.28%28.23%23.84%23.01%23.02%20.75%24.29%23.54%19.17%12.17%
Profit Margin
10.76%11.00%13.63%15.43%18.64%19.38%21.79%21.80%23.36%22.88%21.34%22.50%18.85%17.96%18.31%15.93%19.06%17.87%14.19%8.74%
FCF Margin
20.94%18.76%16.84%15.66%15.52%20.56%23.54%23.52%24.99%23.80%22.55%23.25%18.57%9.92%13.06%18.52%14.76%21.96%16.11%10.79%

Valuation

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
11.3311.2212.5511.108.049.7511.1914.9811.7513.6521.5416.6127.2119.2814.8217.8318.6921.2517.9425.31
Forward PE
7.075.917.787.977.279.189.4212.0410.8912.0920.7717.6023.1418.7516.2915.2719.3322.1616.9617.83
P/FCF Ratio
5.826.5810.1510.949.659.2010.3613.8810.9813.1220.3916.0727.6234.9320.7915.3424.1317.2915.8020.50
PS Ratio
1.221.231.711.711.501.892.443.272.743.124.603.745.133.462.712.843.563.802.552.21